Company Filing History:
2 out of 5 
1 out of 3 
1 out of 1 Years Active: 2016-2018
Title: The Innovative Contributions of Kerstin Dreier
Introduction
Kerstin Dreier is a notable inventor based in Innsbruck, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies for the diagnosis of human papillomavirus (HPV) infections. With a total of 2 patents, her work has the potential to impact public health positively.
Latest Patents
Dreier's latest patents focus on Anti-HPV E7 antibodies. The first patent describes monoclonal anti-HPV E7 antibodies that can specifically recognize an epitope of the C-terminal or the N-terminal region of the HPV E7 protein. This invention includes diagnostic compositions and kits that utilize these antibodies, as well as methods for immunohistochemical and ELISA-based diagnosis of HPV infections. The second patent reiterates the capabilities of these monoclonal antibodies in recognizing the HPV E7 protein, emphasizing their importance in diagnostic applications.
Career Highlights
Throughout her career, Dreier has worked with reputable organizations such as Austria Wirtschaftsservice Gesellschaft mbH and Österreichische Akademie der Wissenschaften. Her experience in these institutions has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Dreier has collaborated with esteemed colleagues, including Werner Zwerschke and Haymo Pircher. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Kerstin Dreier's innovative work in the field of biotechnology, particularly her patents related to Anti-HPV E7 antibodies, showcases her dedication to improving diagnostic methods for HPV infections. Her contributions are vital in the ongoing fight against viral infections and highlight the importance of research in public health.